4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-18-036457
Options or other derivatives
- Chief Financial Officer acquired 132,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pizzie Nick Chief Financial Officer | 2018-05-16 | Grant or award · Employee Stock Option (right to buy) | +132,000 | 132,000 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…